Rashes are a common side effect of some prostate cancer treatments. Rarely, they may be caused by cancer cells.

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

King Charles sent shockwaves around the nation in February 2024 when Buckingham Palace announced that he had been diagnosed ...

Jim Willwerth, in this horticulture discussion, delves into hormonal therapy for grapevines, including plant growth ...

Truqap combination in PTEN-deficient metastatic hormone-sensitive prostate cancer demonstrated statistically significant and ...

Mr Davies continued hormone treatment to reduce his testosterone ... treated him along with information he was given from Prostate Cancer UK.

Prostate cancer accounts for three per cent of all cancers in India, with an estimated 33,000-42,000 new cases diagnosed ...

Basel: Novartis has announced that the US Food and Drug Administration (FDA) has approved Pluvicto (lutetium Lu 177 ...

The U.S. Food and Drug Administration (FDA) on Friday approved Novartis AG’s NVS Pluvicto for prostate cancer patients. The expanded indication, which approximately triples the number of patients ...